跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ILUMYA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ILUMYA
Authorized
STANDARD
ILUMYA
SUN PHARMACEUTICAL INDUSTRIES LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
342f5c334ce82565
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Type
Standard
Approval Details
Approval Id
342f5c334ce82565
Drug Approval Canada Name
ILUMYA
Product Name
ILUMYA
Status
Marketed
Status Date
2022-10-24
Original Market Date
2021-08-04
Din
02516098
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
84:06.28
Atc Original
L04AC17 TILDRAKIZUMAB
Atc Name
l 04 ac 17
Aig Number
0162907001
Company Name
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Company Address
Sun House, Plot 201 B/1, Western Express Highway, Goregaon (E), Mumbai, Maharashtra, India, 400063
Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Company Information
Pharmaceutical Company Name
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Country Name
India
Province Name
Maharashtra
City Name
mumbai,maharashtra,country_in
Address
Sun House, Plot No. 201 B/1
Active Ingredients
TILDRAKIZUMAB
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
342f5c334ce82565
Type
Standard
Back to Health Canada Approvals